science Wired Science 2026-10-24

Personalized mRNA Vaccine Shows Promise Against Melanoma Recurrence

A new Phase 3 trial indicates that a personalized mRNA cancer vaccine can reduce the risk of melanoma recurrence by over 40 percent.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10